Patent directory · USPTO A61K / A61P
Patents matching “CTOR”
756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11773393
Treatment of liver diseases with cell death inducing DFFA like effector B (CIDEB) inhibitors
granted -
US 11760795
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer
granted -
US 11759531
Gene therapy vectors for treating heart disease
granted -
US 11753366
Tetrahydro-1H-cyclopenta[cd]indene derivatives as hypoxia inducible factor-2(alpha) inhibitors
granted -
US 11753461
Optimized factor VIII genes
granted -
US 11739309
CRISPR-Cas12J effector polypeptides and methods of use thereof
granted -
US 11732265
Compositions and methods for modulating complement factor B expression
granted -
US 11707536
Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia A
granted -
US 11690898
Adeno-associated virus Factor VIII vectors, associated viral particles and therapeutic formulations comprising the same
granted -
US 11685909
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 11685771
Recombinant factor VIII proteins
granted -
US 11685775
Method of increasing the ratio of effector T cells to regulatory T cells in a tumor by administering to a subject a TGF-beta inhibitor and a PD-1 antibody
granted -
US 11642398
Factor IX polypeptide formulations
granted -
US 11643394
Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease
granted -
US 11638753
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted -
US 11634482
Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer
granted -
US 11628205
Conjugates of a factor VIII moiety having an oxime-containing linkage
granted -
US 11617801
RP2 and RPGR vectors for treating X-linked retinitis pigmentosa
granted -
US 11612652
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
granted -
US 11596671
Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expression
granted -
US 11591613
Retroviral and lentiviral vectors
granted -
US 11578135
Multispecific antigen-binding molecules binding to a target and an internalizing effector protein that is CD63 and uses thereof
granted -
US 11578313
CRISPR-Cas effector polypeptides and methods of use thereof
granted -
US 11555057
Compositions and methods for inhibiting tumor cells by inhibiting the transcription factor ATF5
granted